Biote (BTMD) Cost of Revenue (2021 - 2023)
Historic Cost of Revenue for Biote (BTMD) over the last 3 years, with Q4 2023 value amounting to $14.0 million.
- Biote's Cost of Revenue fell 919.99% to $14.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $57.9 million, marking a year-over-year increase of 605.04%. This contributed to the annual value of $58.1 million for FY2024, which is 43.71% up from last year.
- Per Biote's latest filing, its Cost of Revenue stood at $14.0 million for Q4 2023, which was down 919.99% from $14.2 million recorded in Q3 2023.
- Biote's 5-year Cost of Revenue high stood at $15.8 million for Q2 2023, and its period low was $11.6 million during Q2 2021.
- Moreover, its 3-year median value for Cost of Revenue was $13.5 million (2022), whereas its average is $13.6 million.
- Within the past 5 years, the most significant YoY rise in Biote's Cost of Revenue was 1692.4% (2023), while the steepest drop was 919.99% (2023).
- Biote's Cost of Revenue (Quarter) stood at $13.5 million in 2021, then rose by 14.03% to $15.4 million in 2022, then fell by 9.2% to $14.0 million in 2023.
- Its last three reported values are $14.0 million in Q4 2023, $14.2 million for Q3 2023, and $15.8 million during Q2 2023.